| Rosanne L Sutter, MD | |
|
211 S 3rd St, Belleville, IL 62220-1915 | |
| (618) 234-2120 | |
| Not Available |
| Full Name | Rosanne L Sutter |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 211 S 3rd St, Belleville, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154422673 | NPI | - | NPPES |
| 036103098 | Medicaid | IL | |
| 08232204 | Other | IL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 036-103098 (Illinois) | Primary |
| Entity Name | Uptown Emergency Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811135882 PECOS PAC ID: 8921096850 Enrollment ID: O20040430001269 |
News Archive
Abbott today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical products and expanding Abbott's presence in key global emerging markets.
A family of small molecules called CFTR inhibitors show promising effects in slowing the progression of polycystic kidney disease (PKD), the most common genetic disease of the kidneys, according to preliminary research reported in the July 2008 issue of the Journal of the American Society Nephrology.
A Loyola University Medical Center psychiatrist is proposing a new subspecialty to diagnose and treat patients who suffer both depression and heart disease. He's calling it "Psychocardiology."
Between 1994 and 2002, the rate of smoking among Canadian youths in Grades 5 to 9 declined by more than half, according to new data from the Youth Smoking Survey.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
› Verified 4 days ago
| Entity Name | Red Bud Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053619148 PECOS PAC ID: 0648454520 Enrollment ID: O20110419000082 |
News Archive
Abbott today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical products and expanding Abbott's presence in key global emerging markets.
A family of small molecules called CFTR inhibitors show promising effects in slowing the progression of polycystic kidney disease (PKD), the most common genetic disease of the kidneys, according to preliminary research reported in the July 2008 issue of the Journal of the American Society Nephrology.
A Loyola University Medical Center psychiatrist is proposing a new subspecialty to diagnose and treat patients who suffer both depression and heart disease. He's calling it "Psychocardiology."
Between 1994 and 2002, the rate of smoking among Canadian youths in Grades 5 to 9 declined by more than half, according to new data from the Youth Smoking Survey.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
› Verified 4 days ago
| Entity Name | Deaconess Illinois Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962128256 PECOS PAC ID: 5092187021 Enrollment ID: O20230220002667 |
News Archive
Abbott today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical products and expanding Abbott's presence in key global emerging markets.
A family of small molecules called CFTR inhibitors show promising effects in slowing the progression of polycystic kidney disease (PKD), the most common genetic disease of the kidneys, according to preliminary research reported in the July 2008 issue of the Journal of the American Society Nephrology.
A Loyola University Medical Center psychiatrist is proposing a new subspecialty to diagnose and treat patients who suffer both depression and heart disease. He's calling it "Psychocardiology."
Between 1994 and 2002, the rate of smoking among Canadian youths in Grades 5 to 9 declined by more than half, according to new data from the Youth Smoking Survey.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
› Verified 4 days ago
| Entity Name | Deaconess Illinois Red Bud Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619693926 PECOS PAC ID: 9537531579 Enrollment ID: O20230221000484 |
News Archive
Abbott today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical products and expanding Abbott's presence in key global emerging markets.
A family of small molecules called CFTR inhibitors show promising effects in slowing the progression of polycystic kidney disease (PKD), the most common genetic disease of the kidneys, according to preliminary research reported in the July 2008 issue of the Journal of the American Society Nephrology.
A Loyola University Medical Center psychiatrist is proposing a new subspecialty to diagnose and treat patients who suffer both depression and heart disease. He's calling it "Psychocardiology."
Between 1994 and 2002, the rate of smoking among Canadian youths in Grades 5 to 9 declined by more than half, according to new data from the Youth Smoking Survey.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
› Verified 4 days ago
| Entity Name | Deaconess Illinois Specialty Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972210235 PECOS PAC ID: 9830562016 Enrollment ID: O20230321001688 |
News Archive
Abbott today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical products and expanding Abbott's presence in key global emerging markets.
A family of small molecules called CFTR inhibitors show promising effects in slowing the progression of polycystic kidney disease (PKD), the most common genetic disease of the kidneys, according to preliminary research reported in the July 2008 issue of the Journal of the American Society Nephrology.
A Loyola University Medical Center psychiatrist is proposing a new subspecialty to diagnose and treat patients who suffer both depression and heart disease. He's calling it "Psychocardiology."
Between 1994 and 2002, the rate of smoking among Canadian youths in Grades 5 to 9 declined by more than half, according to new data from the Youth Smoking Survey.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosanne L Sutter, MD Po Box 8882, Fort Worth, TX 76124-0882 Ph: (817) 451-4208 | Rosanne L Sutter, MD 211 S 3rd St, Belleville, IL 62220-1915 Ph: (618) 234-2120 |
News Archive
Abbott today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical products and expanding Abbott's presence in key global emerging markets.
A family of small molecules called CFTR inhibitors show promising effects in slowing the progression of polycystic kidney disease (PKD), the most common genetic disease of the kidneys, according to preliminary research reported in the July 2008 issue of the Journal of the American Society Nephrology.
A Loyola University Medical Center psychiatrist is proposing a new subspecialty to diagnose and treat patients who suffer both depression and heart disease. He's calling it "Psychocardiology."
Between 1994 and 2002, the rate of smoking among Canadian youths in Grades 5 to 9 declined by more than half, according to new data from the Youth Smoking Survey.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
› Verified 4 days ago
Wallace K Abel, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 311 W Lincoln St Ste 200, Belleville, IL 62220 Phone: 618-234-2566 Fax: 618-234-5650 | |
Dr. Shannon Erin Witty, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 S 3rd St Ste 400, Belleville, IL 62220 Phone: 618-233-7880 | |
Dr. Victoria Oluwaseun Spencer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-6220 Fax: 618-257-6679 | |
Naveen Kumar Reddy Bondalapati, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-233-3066 Fax: 618-257-6679 | |
David J Nyquist, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-6220 Fax: 618-257-6679 | |
Niraj J Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Memorial Dr Ste 210, Belleville, IL 62226 Phone: 618-767-7000 | |
Brett Allen Nance, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 S 3rd St, Suite 400, Belleville, IL 62220 Phone: 618-233-7880 Fax: 618-222-4792 |